article thumbnail

Pharmacy Education Must Keep Pace With Changing Health Care Landscape | ACCP 2024

Drug Topics

Posters presented at ACCP 2024 revealed gaps in pharmacy students’ understanding of off-label drug applications and identified strengths and weaknesses among pharmacy graduates.

Labelling 524
article thumbnail

FDA widens label for BMS’ cancer drug Augtyro

pharmaphorum

FDA widens label for BMS’ cancer drug Augtyro Phil.Taylor Fri, 14/06/2024 - 08:17 Bookmark this

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Newest Indication for Bempedoic Acid Expands Patient Population

Pharmacy Times

In March 2024, the label for bempedoic acid was expanded to reduce cardiovascular risk and expand the low-density lipoprotein-C (LDL-C) lowering in both primary and secondary prevention patients.

Labelling 144
article thumbnail

GLP-1 receptor agonist shortage warning extended by UK Government until end of 2024

Hospital Pharmacy Europe

The supply of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is not expected to return to normal until at least the end of 2024, the UK Government has confirmed. And it warned prescribers not to prescribe GLP-1 RAs licensed for type 2 diabetes for off-label indications.

Labelling 105
article thumbnail

Medication Safety Quiz 2024

OctariusRx

The 2024 version of the OctariusRx medication safety quiz is about to be released. The quiz focuses on some of the most commonly encountered situations, including allergies, labeling medications and controlled substances. The post Medication Safety Quiz 2024 appeared first on OctariusRX. How are you assessing your staff?

article thumbnail

Analytica 2024 in overview

European Pharmaceutical Review

International participation and trending topics With over 900 exhibitors, analytica 2024 promises an impressive lineup. Digitalisation also relieves laboratory personnel through optimised inventory management with online inventory maintenance and automatic label printing, enhancing efficiency and occupational safety.

article thumbnail

AHA 2024: Lerodalciep provides promising results in open-label extension trial, LIBERATE-OLE

Pharmaceutical Technology

At AHA 2024, clinical trial results were presented from the ongoing open-label extension trial, LIBERATE-OLE, involving lerodalciep.